SCHEMBL24760200

SCHEMBL24760200

CC(=O)CCNC(=O)CCC(C)C

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.55
▸ LMNA P02545 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ CA1 P00915 2/20 0.41
▸ NAMPT P43490 2/20 0.41
▸ CNR1 P21554 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ P2RX7 Q99572 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ CASP2 P42575 1/20 0.35
▸ GGPS1 O95749 1/20 0.35
▸ FDPS P14324 1/20 0.35
▸ CNR2 P34972 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ ANPEP P15144 2/20 0.34
▸ RNPEP Q9H4A4 2/20 0.34
▸ DNPEP Q9ULA0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11452609 0.85 ALDH1A1 (0.61) ALDH1A1LMNAPKMCA1NAMPT
SCHEMBL16399076 0.83 ALDH1A1 (0.55) ALDH1A1LMNAPKMCA1NAMPT
SCHEMBL24648935 0.83 ALDH1A1 (0.50) ALDH1A1LMNAPKMNAMPTCNR1
SCHEMBL16248535 0.82 ALDH1A1 (0.53) ALDH1A1LMNAPKMCA1NAMPT
SCHEMBL19751649 0.81 ALDH1A1 (0.47) ALDH1A1LMNAPKMCA1CNR1
SCHEMBL15071678 0.81 SMN1; SMN2 (0.50) ALDH1A1HPGDHTTTDP1
SCHEMBL1518045 0.81 ALDH1A1 (0.57) ALDH1A1LMNAPKMCA1CNR1
SCHEMBL2320293 0.81 ALDH1A1 (0.57) ALDH1A1LMNAPKMCA1CNR1
SCHEMBL16248615 0.81 ALDH1A1 (0.57) ALDH1A1LMNAPKMCA1NAMPT
SCHEMBL24383336 0.80 LMNA (0.55) ALDH1A1LMNAPKMNAMPTCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873291-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-01-16 — — US disclosed
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2023-11-09 — — US disclosed
WO-2022262789-A1 ANTITUMOR COMPOUND AND USE THEREOF 明慧医药(杭州)有限公司 2022-12-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11873291-B2 Quinoline cGAS antagonist compounds CGAS, GLS2, GLS ALDH1A1 4236/4885LMNA 1681/4885PKM 2004/4885
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS CGAS, GLS2, GLS ALDH1A1 4236/4885LMNA 1681/4885PKM 2004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback